ID: ALA3357621

Max Phase: Preclinical

Molecular Formula: C19H20BrN3O4

Molecular Weight: 434.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C#Cc1ccc(COC(=O)N2CCC[C@H]2C(=O)NC[C@@H]2CC(Br)=NO2)cc1

Standard InChI:  InChI=1S/C19H20BrN3O4/c1-2-13-5-7-14(8-6-13)12-26-19(25)23-9-3-4-16(23)18(24)21-11-15-10-17(20)22-27-15/h1,5-8,15-16H,3-4,9-12H2,(H,21,24)/t15-,16-/m0/s1

Standard InChI Key:  KQYFBQDOGGZWJD-HOTGVXAUSA-N

Associated Targets(Human)

Protein-glutamine gamma-glutamyltransferase K 164 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-glutamine gamma-glutamyltransferase 1221 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 434.29Molecular Weight (Monoisotopic): 433.0637AlogP: 2.38#Rotatable Bonds: 5
Polar Surface Area: 80.23Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.10CX LogD: 2.10
Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.72Np Likeness Score: -1.15

References

1. Klöck C, Herrera Z, Albertelli M, Khosla C..  (2014)  Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2.,  57  (21): [PMID:25333388] [10.1021/jm501145a]

Source